Ryan Preblick
Director of Finance/CFO bij INDIVIOR PLC
Vermogen: 1 M $ op 31-03-2024
Profiel
Ryan Preblick is currently the Chief Financial Officer & Executive Director at Indivior PLC since 2020.
He is also currently the Chief Financial Officer, Secretary & Treasurer at Opiant Pharmaceuticals, Inc. Mr. Preblick completed his undergraduate degree at The Pennsylvania State University and holds an MBA from the University of Richmond.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
INDIVIOR PLC
0.05% | 15-03-2024 | 68 386 ( 0.05% ) | 1 M $ | 31-03-2024 |
Actieve functies van Ryan Preblick
| Bedrijven | Functie | Begin |
|---|---|---|
| INDIVIOR PLC | Director of Finance/CFO | 29-06-2020 |
| OPIANT PHARMACEUTICALS, INC. | Director of Finance/CFO | - |
Opleiding van Ryan Preblick
| The Pennsylvania State University | Undergraduate Degree |
| University of Richmond | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| INDIVIOR PLC | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Opiant Pharmaceuticals, Inc.
 Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
